Boehringer and Anthem begin trial to study treatment impact on COPD exacerbations

Boehringer Ingelheim has initiated a pragmatic clinical trial (AIRWISE) in partnership with Anthem and its outcomes research subsidiary HealthCore to investigate the impact of commonly prescribed medicines on exacerbations of chronic obstructive pulm …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news